Skip to content
value.today
Total raised
$84 M
6 rounds on record
Latest round
$5 M
Dec 2019
First round on record
Apr 2013
Today
Private
No later event on record

Funding rounds

6 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Bioquiddity Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Dec 2019$5 MNo. 6$2 to $10 million

Bioquiddity Inc.: Raise no. 6, Dec 2019

Investors in this round

15 investors had bought by the notice of Jan 10, 2020: 15 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$5 M of $19 M offered; $14 M still to sell
Smallest investment taken
no minimum stated
What was sold
debt, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in California

People named in the notice

  • Joshua W. Kriesel · Executive Officer, Director
  • Ron W. Pauli · Executive Officer
  • Christopher J. Portman · Director
  • Daniel J. Tasse · Director
  • Llew J. Keltner · Director
  • Mark J. Ehlert · Director
  • Norvall William Jasper, Jr. · Director
  • Richard J. Nesbit · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Joshua W. Kriesel, Chief Executive Officer and President. Source: SEC Form D, newest notice filed Jan 10, 2020. Read the notice at the SEC.

debt, optionsSEC
Aug 2017$6 MNo. 5$2 to $10 million

Bioquiddity Inc.: Raise no. 5, Aug 2017

Investors in this round

2 investors had bought by the notice of Aug 10, 2017: 2 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$6 M of $6 M offered
Smallest investment taken
no minimum stated
What was sold
options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in California

People named in the notice

  • Joshua W. Kriesel · Executive Officer, Director
  • Ron W. Pauli · Executive Officer
  • Christopher J. Portman · Director
  • Daniel J. Tasse · Director
  • Llew J. Keltner · Director
  • Mark J. Ehlert · Director
  • Norvall William Jasper, Jr. · Director
  • Richard J. Nesbit · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Joshua W. Kriesel, Chief executive officer and president. Source: SEC Form D, newest notice filed Aug 10, 2017. Read the notice at the SEC.

optionsSEC
Oct 2016$15 MNo. 4$10 to $50 million

Bioquiddity Inc.: Raise no. 4, Oct 2016

Investors in this round

1 investor had bought by the notice of Oct 20, 2016: 1 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$15 M of $15 M offered
Smallest investment taken
no minimum stated
What was sold
debt, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
$130,000
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in California

People named in the notice

  • Joshua W. Kriesel · Executive Officer, Director
  • Ron W. Pauli · Executive Officer
  • Christopher J. Portman · Director
  • Daniel J. Tasse · Director
  • Llew J. Keltner · Director
  • Mark J. Ehlert · Director
  • Norvall William Jasper, Jr. · Director
  • Richard J. Nesbit · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • Credo 180, LLC · broker-dealer Trump Securities, LLC (CRD 47107) · New York, New YorkSold in NY

Remarks in the notice

  • On the amounts: “This amount includes $2,040,000 for the exercise price of the warrants.”

Signed by Joshua W. Kriesel, Chief executive officer and president. Source: SEC Form D, newest notice filed Oct 20, 2016. Read the notice at the SEC.

debt, optionsSEC
Nov 2015$36 MNo. 3$10 to $50 million

Bioquiddity Inc.: Raise no. 3, Nov 2015

Investors in this round

52 investors had bought by the notice of Nov 5, 2018: 52 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$36 M of $45 M offered; $9 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
more than a year
Issuer's revenue
Not disclosed
Sales commissions
$102,000
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in California

People named in the notice

  • Joshua W. Kriesel · Executive Officer, Director
  • Ron W. Pauli · Executive Officer
  • Christopher J. Portman · Director
  • Daniel J. Tasse · Director
  • Llew J. Keltner · Director
  • Mark J. Ehlert · Director
  • Norvall William Jasper, Jr. · Director
  • Richard J. Nesbit · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • Canaccord Genuity Inc. (CRD 1020) · New York, New YorkSold in MA

Signed by Joshua W. Kriesel, President. Source: SEC Form D and 2 amendments, newest notice filed Nov 5, 2018. Read the notice at the SEC.

equitySEC
Oct 2014$14 MNo. 2$10 to $50 million

Bioquiddity Inc.: Raise no. 2, Oct 2014

Investors in this round

2 investors had bought by the notice of Nov 10, 2014: 2 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$14 M of $14 M offered
Smallest investment taken
no minimum stated
What was sold
debt, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
$250,000
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in California

People named in the notice

  • Joshua W. Kriesel · Executive Officer, Director
  • Ron W. Pauli · Executive Officer
  • Christopher J. Portman · Director
  • Llew J. Keltner · Director
  • Mark J. Ehlert · Director
  • Norvall William Jasper, Jr. · Director
  • Richard J. Nesbit · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • Armentum Partners LLC · broker-dealer Trump Securities, LLC (CRD 47107) · San Francisco, CaliforniaSold in CA

Remarks in the notice

  • On fees: “In addition, a warrant exercisable for $112,000 of common stock was issued as part of the sales commission, which amount has been included in Item 13 above.”
  • On the amounts: “The total offering amount includes $1,237,000.00 for the exercise price for warrants.”

Signed by Joshua W. Kriesel, President. Source: SEC Form D, newest notice filed Nov 10, 2014. Read the notice at the SEC.

debt, optionsSEC
Apr 2013$8 MNo. 1$2 to $10 million

Bioquiddity Inc.: Raise no. 1, Apr 2013

Investors in this round

51 investors had bought by the notice of Apr 19, 2013: 51 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$8 M of $15 M offered; $7 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in California

People named in the notice

  • Joshua W. Kriesel · Executive Officer, Director
  • Christopher A. Portman · Director
  • Llew J. Keltner · Director
  • Mark J. Ehlert · Director
  • Marshall S. Kriesel · Director
  • Richard A. Nesbit · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Joshua W. Kriesel, President. Source: SEC Form D, newest notice filed Apr 19, 2013. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Bioquiddity Inc. chose not to state its revenue in its newest notice of a funding round (Jan 2020).

    SEC Form D · Jan 2020

  • The industry group it chose in its notices: Other.

    SEC Form D · Jan 2020

That is all the official record says: Bioquiddity Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Bioquiddity Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 6 rounds above had up to 52 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Bioquiddity Inc.
NameRoleNamed in
Joshua W. KrieselExecutive officerJan 2020
Ron W. PauliExecutive officerJan 2020
Christopher J. PortmanDirectorJan 2020
Daniel J. TasseDirectorJan 2020
Joshua W. KrieselDirectorJan 2020
Llew J. KeltnerDirectorJan 2020
Mark J. EhlertDirectorJan 2020
Norvall William Jasper, Jr.DirectorJan 2020
Richard J. NesbitDirectorJan 2020
Christopher A. PortmanDirectorApr 2013
Marshall S. KrieselDirectorApr 2013
Richard A. NesbitDirectorApr 2013